End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 31 | BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 | CI |
Feb. 04 | BG Medicine Announces Board Changes | CI |
Business Summary
Sales per Business
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Solutions
89.7
%
| 3 | 100.0 % | 1 | 89.7 % | -49.59% |
Product Fee
8.9
%
| - | - | 0 | 8.9 % | - |
Partnership Revenue
1.3
%
| - | - | 0 | 1.3 % | - |
Sales per region
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -43.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephen Hall
DFI | Director of Finance/CFO | 73 | 13-12-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Wilcox
CHM | Chairman | 69 | 15-05-11 |
Jeffrey R. Luber
BRD | Director/Board Member | 57 | 16-02-03 |
James O'Connor
BRD | Director/Board Member | 67 | 15-11-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,474,443 | 0 | 0 | 100.00 % |
Stock B | 1 | 11,374,360 | 11,374,360 ( 100.00 %) | 0 |
Company contact information
BG Medicine, Inc.
124 Washington Street Suite 101
02035, Foxboro
+781 890 1199
http://www.bg-medicine.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-15.39% | 1.59B | |
-14.83% | 60.31M |
- Stock
- Equities
- Stock BG Medicine, Inc.
- Stock BG Medicine - Nasdaq
- Company BG Medicine